Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IIOngoingApr 29, 20260.9 % SODIUM CHLORIDE IRRIGATIONLack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.B Braun Medical Inc · D-0497-2026Class IIOngoingApr 29, 2026DEXTROSE INJECTION USPLack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.B Braun Medical Inc · D-0496-2026Class IIOngoingApr 29, 2026Sterile Water for Injection USPLack of Assurance of Sterility; potential for leakage from the diaphragm port once the foil is removed.B Braun Medical Inc · D-0495-2026Class IIOngoingApr 29, 2026Omega-3-AcidFailed Capsule Specifications: Out of specification results obtained during routine stability testing for Loss on Drying of Capsule Shells.The Harvard Drug Group LLC · D-0493-2026Class IIIOngoingApr 29, 2026Premier, Monsel'sLabeling: Incorrect or Missing Lot and/or Exp Date:The expiration date has an extra digit and is printed as 2709114 instead of the correct 270914 (2027-09-14). It is...Premier Dental Products Co · D-0490-2026Class IIOngoingApr 29, 2026FRESHKOTE LUBRICANT EYEDROPSLack of Assurance of SterilityHarrow Eye LLC · D-0489-2026Class IIOngoingApr 29, 2026Furosemide TabletsCGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.Leading Pharma, LLC · D-0486-2026Class IIOngoingApr 29, 2026Pantoprazole SodiumDiscoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."Hetero Labs Limited (Unit V) · D-0484-2026Class IIOngoingApr 22, 2026Lidocaine HCl InjectionLack of Assurance of SterilityHuons Co., Ltd. · D-0532-2026Class IIOngoingApr 22, 20260.9% Sodium Chloride InjectionLack of Assurance of SterilityHuons Co., Ltd. · D-0531-2026Class IIOngoingApr 22, 2026Bupivacaine Hydrochloride 0.75% in 8.25% Dextrose InjectionLack of Assurance of SterilityHuons Co., Ltd. · D-0530-2026Class IIOngoingApr 22, 2026Lidocaine HCl injectionLack of Assurance of SterilityHuons Co., Ltd. · D-0529-2026Class IIOngoingApr 22, 2026Desmopressin Nasal SprayDefective container: defect in a batch of bottle caps, specifically involving dislodged or missing cap liners.Apotex Corp. · D-0510-2026Class IIIOngoingApr 22, 2026Magnesium ChlorideSubpotent drugAvantor Performance Materials LLC · D-0488-2026Class IIOngoingApr 22, 2026Blemish Spot TreatmentFailed Stability SpecificationsIsland Kinetics, Inc. d.b.a. CoValence Laboratories · D-0487-2026Class IIOngoingApr 22, 2026Memantine Hydrochloride Extended-ReleaseFailed Dissolution SpecificationsThe Harvard Drug Group LLC · D-0485-2026Class IIOngoingApr 22, 2026EPINEPHRINE InjectionLack of Assurance of SterilityInternational Medication Systems Ltd. · D-0483-2026Class IIITerminatedApr 22, 2026Essential Calming Skin GelSubpotent DrugIsland Kinetics, Inc. d.b.a. CoValence Laboratories · D-0482-2026Class IIITerminatedApr 22, 2026Skin RehabSubpotent DrugIsland Kinetics, Inc. d.b.a. CoValence Laboratories · D-0481-2026Class IIITerminatedApr 22, 2026Remedy GelSubpotent DrugIsland Kinetics, Inc. d.b.a. CoValence Laboratories · D-0480-2026Class IIOngoingApr 22, 2026Albuterol Sulfate Inhalation SolutionLabelling: Illegible labelNephron SC, LLC · D-0479-2026Class IIOngoingApr 22, 2026FluocinonideFailed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.Sun Pharmaceutical Industries Inc · D-0477-2026Class IIOngoingApr 22, 2026FluocinonideFailed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.Sun Pharmaceutical Industries Inc · D-0476-2026Class IIOngoingApr 22, 2026FluocinonideFailed Viscosity Specifications: Out of Specification results, above the specification limit, in viscosity, noted during stability testing.Sun Pharmaceutical Industries Inc · D-0475-2026Class IIOngoingApr 22, 2026Semaglutide-Glycine-Cyanocobalamin InjectableLack of Assurance of SterilityPayless Compounders, LLC · D-0471-2026Class IIOngoingApr 22, 2026QC Quality ChoiceThis recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility...Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · D-0470-2026Class IIOngoingApr 22, 2026QC Quality ChoiceThis recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility...Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · D-0469-2026Class IIOngoingApr 22, 2026QC Quality ChoiceThis recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility...Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · D-0468-2026Class IIOngoingApr 22, 2026QC Quality ChoiceThis recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility...Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · D-0467-2026Class IIOngoingApr 22, 2026QC Quality ChoiceThis recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility...Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · D-0466-2026Class IIOngoingApr 22, 2026QC Quality ChoiceThis recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility...Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · D-0465-2026Class IIOngoingApr 22, 2026QC Quality ChoiceThis recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility...Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · D-0464-2026Class IIOngoingApr 22, 2026MGC HealthThis recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility...Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · D-0463-2026Class IIOngoingApr 22, 2026MGC HealthThis recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility...Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · D-0462-2026Class IIOngoingApr 22, 2026MGC HealthThis recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility...Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · D-0461-2026Class IIOngoingApr 22, 2026Discount Drug Mart Food MarketThis recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility...Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · D-0460-2026Class IIOngoingApr 22, 2026Discount Drug Mart Food MarketThis recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility...Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · D-0459-2026Class IIOngoingApr 22, 2026caring millThis recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility...Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · D-0458-2026Class IIOngoingApr 22, 2026exchange selectThis recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility...Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · D-0457-2026Class IIOngoingApr 22, 2026exchange selectThis recall is being initiated following FDA's recommendation based on certain observations noted during an August 15, 2025, inspection of the manufacturing facility...Xiamen Kang Zhongyuan Biotechnology Co., Ltd. · D-0456-2026

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.